Bharat Bio successfully completes Phase III trials of new oral...

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

Posted

147

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Please log in to like, share and comment!

Entertainment

R Madhavan compares Aap Jaisa Koi to Rishi-Juhi's Bol Radha Bol

R Madhavan, celebrated for his romantic roles, addresses age gaps with co-stars, drawing...

By 0 10

International

Worrisome’: US visa delays hit all-time high, 11.3 million cases pending

USCIS faces mounting immigration case backlogs, reaching 11.3 million pending applications due to...

By 0 12

National

Opposition protest halts Madhesh Provincial Assembly for fourth consecutive day

JANAKPURDHAM: The Madhesh Provincial Assembly meeting was once again disrupted today, marking the...

By 0 10

National

Employees in Rolpa’s Thabang rural municipality disappear

KATHMANDU: Seven employees, including the chief administrative officer of Rolpa’s Thabang...

By 0 11

Business

ICICI Prudential AMC IPO: Fund house plans mega Rs 10,000 crore offering; files Draft Red Herring Prospectus

ICICI Prudential AMC has filed for a Rs 10,000 crore IPO with SEBI, offering 10% of its equity....

By 0 18